Mov Disord Vol 35, Suppl 1 Archives - Page 82 of 149 - MDS Abstracts

MDS Virtual Congress 2020
Low dose Cabergoline for freezing of gait in advanced Parkinson’s disease – you can have your cake and eat it too!
N. Sharma, A. Kumari, N. Sawal, H. Singh, K. Shukla (Chandigarh, India)
Objective: To evaluate efficacy of cabergoline for treating FOG in advanced IPD. Background: FOG is a major cause of disability in advanced IPD. FOG responds…
MDS Virtual Congress 2020
Distribution of intranasal hNSCs in a mouse model of MPTP-induced Parkinson’s disease
F. Wang, Y.T Zhang, S.Z Wei, C. Ren, C.F Liu (Suzhou, China)
Objective: We aimed to map the distribution of human neural stem cells (hNSCs) in the brain and peripheral tissues after intranasal administration in a mouse…
MDS Virtual Congress 2020
Disease stage and UMSARS progression: Implications for clinical trials
M. Pérez, J.A Palma, L. Norcliffe-Kaufmann, P. Millar Vernetti, W. Singer, P. Low, M.T Pellecchia, H.J Kim, C. Shibao, A. Peltier, I. Biaggioni, D. Giraldo, M.J Martí, A. Fanciulli, C. Terroba-Chambi, M. Merello, D. Goldstein, R. Freeman, C. Gibbons, S. Vernino, F. Krismer, G. Wenning, H. Kaufmann (New York, NY, USA)
Objective: To study the rate of progression of multiple system atrophy (MSA) and assess for a potential ceiling effect of the Unified Multiple System Atrophy…
MDS Virtual Congress 2020
Cognitive Differences Between Men and Women with Progressive Supranuclear Palsy
E. Bayram, J. Jankovic, S. Reich, C. Marras, Y. Bordelon, D. Shprecher, R. Dubinsky, I. Litvan (La Jolla, CA, USA)
Objective: (1) To evaluate the cognitive differences between men and women with progressive supranuclear palsy (PSP) and (2) to investigate whether sex has an effect…
MDS Virtual Congress 2020
Gait initiation in patients with Progressive Supranuclear Palsy: a biomechanical and FDG-PET study
M. Todisco, C. Palmisano, G. Marotta, C. Pacchetti, G. Pezzoli, I. Isaias (Würzburg, Germany)
Objective: To define the brain metabolic abnormalities related to gait initiation (GI) failure in subjects with Progressive Supranuclear Palsy (PSP). Background: PSP is an atypical…
MDS Virtual Congress 2020
Personal Kinetigraph and Deep Brain Stimulation with Parkinson’s Disease
A. Potter, G. Newsome, G. Kern, A. Parsons, D. Page, Y. Dalati, C. Sidiropoulos MD (East Lansing, MI, USA)
Objective: To better understand the utility of a wearable wrist sensor in assessing and managing motor fluctuations in a population of patients with advanced Parkinson…
MDS Virtual Congress 2020
Utility of VMAT2 inhibitors in management of stereotypy in children: a series of six patients
M. Hull, M. Parnes (Houston, TX, USA)
Objective: We aim to evaluate the effectiveness of VMAT2 inhibitors in the treatment of stereotypy. Background: Stereotypies are continual, rhythmic, patterned movements that can occur in typically-developing children, and are…
MDS Virtual Congress 2020
A Case of Lance Adams Syndrome with See-Saw Nystagmus
G. Keeton, T. Ali, P. Sudhakar, Z. Guduru (Lexington, KY, USA)
Objective: We present a case of Lance Adams syndrome (LAS) with see-saw nystagmus (SSN). LAS is a rare entity and first reported by Lance and Adams…
MDS Virtual Congress 2020
The Relationship Between Modified Four Square Step Test (mFSST) and Outcome Measures Related to Fall Risk and Quality of Life in Individuals with Parkinson’s Disease
A. Boddy, K. Mitchell, W. Brewer, J. Ellison (St. Augustine, FL, USA)
Objective: Determine the relationship between the modified Four Square Step Test and outcome measures related to fall risk and quality of life in individuals with…
MDS Virtual Congress 2020
How does the perception of fall risk influence behavior in people with Parkinson’s disease?
Y. Huang, J. Song, L. Clemson, N. Allen (Lidcombe, Australia)
Objective: To explore perceptions regarding fall risk and how these perceptions influence behavior in people with Parkinson’s disease (PD) and a history of falls, and…